Clinical trial
Diet, Exercise and/or Rosiglitazone for HIV-Associated Insulin Resistance
NCT00264251 · St. Luke's-Roosevelt Hospital Center, Other · Completed
Key facts
| NCT number | NCT00264251 |
|---|---|
| Title | Diet, Exercise and/or Rosiglitazone for HIV-Associated Insulin Resistance |
| Official title | Effect of Diet, Exercise and Rosiglitazone on Regional Fat and Insulin Resistance in HIV-Infected and Uninfected Men and Women |
| Lead sponsor | St. Luke's-Roosevelt Hospital Center, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections, Insulin Resistance, Obesity |
| Intervention type | Behavioral, Drug |
| Interventions | Weight loss through diet and exercise, Rosiglitazone insulin sensitizing agent |
| Enrollment | 48 |
| Start date | Jul 1, 2005 |
| Completion | Aug 1, 2007 |
| First posted | Dec 12, 2005 |
| Last update posted | Oct 29, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: